In this issue:
Adding primary tumour resection to systemic therapy in metastatic breast cancer
Respiratory viral infections awaken metastatic breast cancer cells in lungs
Elinzanetant for vasomotor symptoms from endocrine therapy for breast cancer
Vepdegestrant in advanced breast cancer
First-line camizestrant for emerging
ESR1-mutated advanced breast cancer
Extending endocrine treatment duration for early breast cancer
Short preoperative endocrine therapy in oestrogen receptor +, HER2+ early breast cancer
Electronic PROs with vital sign monitoring during trastuzumab deruxtecan
Utidelone + bevacizumab for HER2–metastatic breast cancer with brain metastases
Adjuvant capecitabine in triplenegative breast cancer after neoadjuvant chemotherapy
Please login below to download this issue (PDF)